Tag Archives: gamechanging

Biogen’s potentially game-changing Alzheimer’s drug still faces an uphill battle with the FDA

A scientist works in a lab at Biogen in Cambridge, MA on Nov. 5, 2016. Suzanne Kreiter | Boston Globe | Getty Images Biogen pleased shareholders this week after it presented more data on its late-stage Alzheimer’s drug, aducanumab. Shares of the biotech firm closed up 3.41% on Thursday as analysts pointed to a lack of… Read More »